← Browse by Condition
Medical Condition
hodgkin lymphoma
Total Trials
9
Recruiting Now
9
Trial Phases
Phase 1, Phase 2, Phase 2, EARLY_Phase 1
Lymphoma trials span diffuse large B-cell lymphoma (DLBCL), follicular lymphoma, Hodgkin lymphoma, mantle cell lymphoma, and T-cell lymphomas β€” each with distinct biology and treatment response. CAR-T cell therapy has established a new standard in relapsed/refractory DLBCL, and trials now aim to move this approach earlier in the treatment sequence.
Active trials evaluate bispecific antibodies (mosunetuzumab, epcoritamab, glofitamab), next-generation CAR-T cell products (CD19/CD22 dual targets, BCMA-targeting), BTK inhibitors in B-cell lymphomas, and total metabolic volume on PET as a predictive biomarker for treatment adaptation.
Frequently Asked Questions — hodgkin lymphoma Clinical Trials
How many clinical trials are currently recruiting for hodgkin lymphoma?
ClinicalMetric currently tracks 9 actively recruiting clinical trials for hodgkin lymphoma, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 9. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for hodgkin lymphoma?
hodgkin lymphoma research spans Phase 1 (4 trials), Phase 2 (3 trials), Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a hodgkin lymphoma clinical trial?
Eligibility criteria for hodgkin lymphoma trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1 4
Phase 2 3
Phase 3 1
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT04491370 Phase 1, Phase 2
Recruiting
Enrollment
20 pts
Location
United States
Sponsor
New York Medical College
NCT04888741 Phase 2
Recruiting
Enrollment
400 pts
Location
United Kingdom
Sponsor
University of Birmingham
NCT07234487 Phase 2
Recruiting
Enrollment
178 pts
Location
Russia
Sponsor
St. Petersburg State Pavlov Me...
NCT05595577
Recruiting
Enrollment
110 pts
Location
United States
Sponsor
Wake Forest University Health ...
NCT06398457 EARLY_Phase 1
Recruiting
Enrollment
8 pts
Location
United States
Sponsor
Sidney Kimmel Comprehensive Ca...
NCT04685616 Phase 3
Recruiting
Enrollment
1,042 pts
Location
United States, Austr...
Sponsor
University College, London
NCT07623850 Phase 1
Recruiting
Enrollment
115 pts
Location
China
Sponsor
Jecho Biopharmaceuticals Co., ...
NCT06383338 Phase 1
Recruiting
Enrollment
10 pts
Location
Australia
Sponsor
Murdoch Childrens Research Ins...
NCT05839210
Recruiting
Enrollment
140 pts
Location
United States
Sponsor
University of Miami
Related Conditions
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology